Literature DB >> 10730868

Cyclosporin A-induced autoimmunity: the result of defective de novo T-cell development.

J G Damoiseaux1, P J van Breda Vriesman.   

Abstract

Cyclosporin A-induced autoimmunity (CsA-AI) is an autoimmune disease, caused by the combinatory treatment with irradiation and cyclosporin A (CsA). CsA-AI is the result of defective T-cell maturation leading to disturbed T-cell balances in the periphery. Increases in Th1 cells and reduction of autoregulatory cells eventually enable the enumerated autoreactive CD4 and CD8 T cells to disturb the homeostasis in the target organs. In unravelling the effect of CsA on T-cell maturation and the role of T cells in CsA-AI many pieces have been put in their places; nevertheless, some remain the topic of debate. The identity of the autoantigen(s) remains elusive, the working mechanism of the autoregulatory cells still is to be determined, and the interplay between CD4 and CD8 T-cell subsets in relation to type-1 and type-2 responses is a matter of interest. In spite of all these unknowns, the CsA-AI autoimmune model is, in contrast to many autoimmune models induced by immunization with a foreign protein in adjuvant, an interesting physiological model based on defective T-cell development including aberrant selection in the thymus and disturbed T-cell balances in the periphery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10730868

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  5 in total

1.  Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence.

Authors:  Francesca Lodato; Maria-Rosa Tame; Antonio Colecchia; Chiara Racchini; Francesco Azzaroli; Antonia D'Errico; Silvia Casanova; Antonio Pinna; Enrico Roda; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

2.  A dominant role for non-MHC gene effects in susceptibility to cyclosporin A (CsA)-induced autoimmunity.

Authors:  J G Damoiseaux; L J Beijleveld; P J van Breda Vriesman
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

3.  Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells.

Authors:  Heather Kopf; Gonzalo M de la Rosa; O M Zack Howard; Xin Chen
Journal:  Int Immunopharmacol       Date:  2007-09-20       Impact factor: 4.932

4.  De novo autoimmune hepatitis following liver transplantation for primary biliary cirrhosis: an unusual cause of late grafts dysfunction.

Authors:  Rym Ennaifer; Hend Ayadi; Haifa Romdhane; Meriem Cheikh; Hafedh Mestiri; Taher Khalfallah; Najet Bel Hadj
Journal:  Pan Afr Med J       Date:  2015-05-04

Review 5.  Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments.

Authors:  Benedetta Terziroli Beretta-Piccoli; Giorgina Mieli-Vergani; Diego Vergani
Journal:  World J Gastroenterol       Date:  2017-09-07       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.